# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Oct 17, 2016

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2016-10-17
- Accepted by EDGAR: Oct 17, 2016, 12:39 ET
- Period: 2016-10-13
- Accession: 0000875320-16-000098
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532016000098/a8-kbankofamericacreditagr.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532016000098/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 2.04: Item not in the standard list

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532016000098/a8-kbankofamericacreditagr.htm

Filed Oct 17, 2016.
Source: SEC EDGAR, the filing index for accession 0000875320-16-000098. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.